A recent genome-wide association and interaction study (GWAIS) identified GRIN2A, which encodes an NMDA-glutamate-receptor subunit involved in brain's excitatory neurotransmission, as a PD genetic modifier in inverse association with caffeine intake (pinteraction = 3 × 10−5) [64]. This evidence concerns the gene GRIN2A and Parkinson disease.